A head-to-head trial in critically ill patients found that a novel prokinetic drug and metoclopramide performed equally well at reversing intolerance to enteral feeding.
Strategies to address feeding intolerance in critically ill patients is an important unmet need. Despite mixed evidence for the effectiveness of metoclopramide in past studies for this indication, both treatments demonstrated high rates of success with no difference in the rate of adverse events, according to the researchers,